2006
DOI: 10.1159/000092836
|View full text |Cite
|
Sign up to set email alerts
|

Grover’s Disease Induced by Cetuximab

Abstract: A 71-year-old man exhibited an acute acneiform rash affecting the face and the upper trunk about 2 weeks after starting cetuximab, an epidermal growth factor (EGF) receptor antagonist treatment for metastatic colon cancer. The skin eruption faded after stopping cetuximab and applying topical corticosteroids. The reexposure to cetuximab 3 weeks later provoked a more extended relapse of the skin rash, which then clinically and histologically corresponded to transient acantholytic dermatosis . While the acneiform… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
2

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(13 citation statements)
references
References 27 publications
0
11
0
2
Order By: Relevance
“…Quite recently, a case of cetuximab-induced GD was reported in an oncologic patient [13]. Our patient received chemotherapy eleven years prior GD onset and has recorded no NHL relapse to date.…”
Section: Discussionmentioning
confidence: 87%
“…Quite recently, a case of cetuximab-induced GD was reported in an oncologic patient [13]. Our patient received chemotherapy eleven years prior GD onset and has recorded no NHL relapse to date.…”
Section: Discussionmentioning
confidence: 87%
“…A single case of transient acantholytic dermatosis during cetuximab therapy is reported in the literature. 60 …”
Section: Epidermal Growth Factor Receptor Inhibitorsmentioning
confidence: 99%
“…Skin lesions are typically polymorphous in the form of papulovesicles or smooth light erythematous or brownish papules, with crusts or keratotic surface, in nummular, herpetiform or zosteriform distribution or may confluent into plaques [4]. The skin lesions mainly affect the trunk and the back, upper extremities and thighs, but may also have an atypical extensive presentation especially in patients suffering from malignancy, during the course of oncologic treatment or in transplants [11][12][13][14][15][16][17][18][19][20]. Given that Grover's disease has been shown to be associated with hematological or visceral malignancies, it is of the utmost importance to examine the patient in that direction as well [4].…”
Section: Discussionmentioning
confidence: 99%